Skip to content

Effects of Ischemic Postconditioning on MicroRNAs in Double Valve Replacement

Effects of Ischemic Postconditioning on Expression of Apoptosis-related MicroRNAs and Genes in Human Double Valve Replacement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01804283
Enrollment
8
Registered
2013-03-05
Start date
2013-03-31
Completion date
Unknown
Last updated
2013-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary Bypass, Ischemic Postconditioning

Brief summary

1. Cardiopulmonary bypass and cardioplegic arrest could regulate expression of microRNAs in patients undergoing double valve replacement (aortic and mitral). 2. The modulation of myocardial microRNAs by cardiopulmonary bypass and cardioplegic arrest may be rescued by ischemic postconditioning. 3. Downstream effectors would also be affected.

Interventions

multiple brief ischemic-reperfusion episodes immediately after sustained ischemic insult Postconditioning was started at 30 s after aortic cross declamping, and the aorta was re-clamped for 30 s rendering global myocardial ischemia. Meanwhile aortic root suction was established during aortic re-clamping, and thereafter, the aortic clamp was released for 30 s for full myocardial reperfusion. The cycle was repeated three times after cardioplegic arrest.

The double valve replacement is a procedure in which surgery is used to replace diseased aortic and mitral heart valves.

DEVICEheart-lung machine

The heart-lung machine is commonly used in open heart surgery including double valve replacement to support the circulation during the operation.

DEVICEAortic cross-clamp

a surgical instrument used in cardiac surgery to clamp the aorta

Sponsors

Central South University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Consecutive eight patients with rheumatic heart valve disease undergoing elective double valve replacement(aortic and mitral)are considered for participation in this study.

Exclusion criteria

* insulin-dependent diabetes mellitus * pulmonary, renal, or hepatic failure * infective valve disease * valve disease with coronary artery disease * hypertension * emergency and reoperations * received aspirin,corticosteroids, or statin preoperatively * received preoperative inotropic support

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Cardiac MicroRNA Expressionbefore cardiopulmonary bypass and at 5 min after aortic de-clampingSamples were harvested from all the patients, respectively, before cardiopulmonary bypass and at 5 min after aortic de-clamping. Real-time quantitative stem-loop reverse transcription polymerase chain reaction assay was performed to detect the expression of microRNAs.

Secondary

MeasureTime frameDescription
Change from Baseline in Downstream Gene Expressionbefore cardiopulmonary bypass and at 5 min after aortic de-clampingExpressions of messenger RNAs and proteins were quantified for genes which are regulated by above-detected microRNAs.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026